Charles W. Newton, Chief Financial Officer at Lyell Immunopharma, Inc. (LYEL), sold 267 shares at $10.34 ($3K) on 2025-08-12, disclosed to the SEC on 2025-08-13.
Open-market sale of $3k LYEL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.53 | 131 | $1K | 49.5% |
| 2 | $10.34 | 136 | $1K | 50.5% |
| Total | $10.43 avg | 267 | $3K | 100% |
| Filing → |
| LYEL | SELL | 2025-08-22 | $15K | — | Filing → |
| LYEL | BUY | 2025-03-18 | $224K | — | Filing → |